Fig. 2From: Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance databaseForest plot of associations between concurrent drugs exposures with risk AKI in patients with ICIs. PPI Proton pump inhibitors, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker, NSAID Nonsteroidal anti-inflammatory drug, AKI Acute kidney injury, ICIs Immune checkpoint inhibitorsBack to article page